BioCentury | Oct 4, 2019
Company News

Management tracks: J&J hires Bayer’s Swanson; plus Torque, Dynavax, Pact, Deciphera, NextCure, Retrophin, Verve, Jnana and more

...global marketing for the food protection business of Thermo Fisher Scientific Inc. (NYSE:TMO). Tools company NanoString Technologies Inc....
...Pharma Inc. Deciphera Pharmaceuticals Inc. NextCure Inc. Retrophin Inc. Vor Biopharma Inc. Pharmaceutical Research and Manufacturers of America (PhRMA) Verve Therapeutics Inc. NanoString Technologies Inc. Johnson...
BioCentury | Jul 26, 2019
Preclinical News

July 26 preclinical Quick Takes: Ribon's new mechanism for PARP inhibitors, a microbiome-ALS link and more

...model of peripheral artery insufficiency. Vanderbilt links encephalitis to checkpoint inhibitors A Vanderbilt University and NanoString Technologies Inc....
...TYK2 - tyrosine kinase 2 Hongjiang Li and Sandi Wong, Staff Writers BMS-986165 BiomX Ltd. Bristol-Myers Squibb Co. Cytokinetics Inc. DayTwo Ltd. NanoString Technologies Inc. Ribon...
BioCentury | Mar 20, 2019
Financial News

Follow-on roundup: Dermira, resTORbio, NanoString

...an upsized offering that followed closely after its eczema readout this week, while resTORbio and NanoString...
...elderly patients. The therapy is an inhibitor of mammalian target of rapamycin complex 1 (mTORC1). NanoString Technologies Inc....
...NanoString's closing price of $27.27 on Monday, when it proposed the offering after market hours; NanoString...
BioCentury | Feb 1, 2019
Tools & Techniques

TMB needs company

...with Nanostring Technologies Inc. (see Figure: “Inflammatory Expressions”). Figure: Inflammatory expressions Merck & Co. Inc. (NYSE:MRK) and Nanostring Technologies Inc....
...gene expression profile (GEP) biomarker to predict patient responses to checkpoint inhibitors. The biomarker uses Nanostring's...
...Memorial Sloan Kettering Cancer Center, New York, N.Y. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. NanoString Technologies Inc....
BioCentury | Jan 12, 2019
Finance

JPM jump-starts 2019

...Inc. (NASDAQ:CLVS) 31% $24.08 Novocure Ltd. (NASDAQ:NVCR) 29% $43.25 Sosei Group Corp. (Tokyo:4565) 28% ¥1,110 NanoString Technologies Inc....
BioCentury | Jul 20, 2018
Financial News

NanoString prices follow-on, reports preliminary earnings

...Molecular diagnostic company NanoString Technologies Inc. (NASDAQ:NSTG) raised $50 million on July 17 through the sale of 4...
...NanoString's close of $15.10 on July 16 when it proposed the offering after market hours. NanoString...
...Gene Signature Assay (pam50-based gene expression test for breast cancer, NanoString Breast Cancer Intrinsic Subtyping Assay) NanoString Technologies Inc....
BioCentury | Jul 17, 2018
Financial News

NanoString prices follow-on, reports preliminary earnings

...Molecular diagnostic company NanoString Technologies Inc. (NASDAQ:NSTG) raised $50 million through the sale of 4 million shares at...
...by J.P. Morgan, UBS Investment Bank and Baird. The price is a 17% discount to NanoString's...
...Gene Signature Assay (pam50-based gene expression test for breast cancer, NanoString Breast Cancer Intrinsic Subtyping Assay) NanoString Technologies Inc....
BioCentury | Jun 9, 2018
Finance

ASCO ascent

...$31.33 13% Sierra Oncology Inc. (NASDAQ:SRRA) $3.16 12% Oncolytics Biotech Inc. (NASDAQ:ONCY; TSX:ONC) $6.97 11% NanoString Technologies Inc....
BioCentury | Jan 19, 2018
Clinical News

OncoSec reports preliminary Phase I data for ImmunoPulse IL-12 in TNBC

...The open-label, U.S. trial is evaluating changes in the proportion of intratumoral lymphocyte subsets and NanoString-based...
...metastatic triple-negative breast cancer (TNBC) Endpoint: Changes in the proportion of intratumoral lymphocyte subsets and NanoString-based...
BioCentury | Jan 17, 2018
Company News

Management tracks: NanoString, Orchard

...Molecular diagnostics company NanoString Technologies Inc. (NASDAQ:NSTG) hired Thomas Bailey as CFO. He was CFO of AgaMatrix Holdings...
Items per page:
1 - 10 of 103
BioCentury | Oct 4, 2019
Company News

Management tracks: J&J hires Bayer’s Swanson; plus Torque, Dynavax, Pact, Deciphera, NextCure, Retrophin, Verve, Jnana and more

...global marketing for the food protection business of Thermo Fisher Scientific Inc. (NYSE:TMO). Tools company NanoString Technologies Inc....
...Pharma Inc. Deciphera Pharmaceuticals Inc. NextCure Inc. Retrophin Inc. Vor Biopharma Inc. Pharmaceutical Research and Manufacturers of America (PhRMA) Verve Therapeutics Inc. NanoString Technologies Inc. Johnson...
BioCentury | Jul 26, 2019
Preclinical News

July 26 preclinical Quick Takes: Ribon's new mechanism for PARP inhibitors, a microbiome-ALS link and more

...model of peripheral artery insufficiency. Vanderbilt links encephalitis to checkpoint inhibitors A Vanderbilt University and NanoString Technologies Inc....
...TYK2 - tyrosine kinase 2 Hongjiang Li and Sandi Wong, Staff Writers BMS-986165 BiomX Ltd. Bristol-Myers Squibb Co. Cytokinetics Inc. DayTwo Ltd. NanoString Technologies Inc. Ribon...
BioCentury | Mar 20, 2019
Financial News

Follow-on roundup: Dermira, resTORbio, NanoString

...an upsized offering that followed closely after its eczema readout this week, while resTORbio and NanoString...
...elderly patients. The therapy is an inhibitor of mammalian target of rapamycin complex 1 (mTORC1). NanoString Technologies Inc....
...NanoString's closing price of $27.27 on Monday, when it proposed the offering after market hours; NanoString...
BioCentury | Feb 1, 2019
Tools & Techniques

TMB needs company

...with Nanostring Technologies Inc. (see Figure: “Inflammatory Expressions”). Figure: Inflammatory expressions Merck & Co. Inc. (NYSE:MRK) and Nanostring Technologies Inc....
...gene expression profile (GEP) biomarker to predict patient responses to checkpoint inhibitors. The biomarker uses Nanostring's...
...Memorial Sloan Kettering Cancer Center, New York, N.Y. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. NanoString Technologies Inc....
BioCentury | Jan 12, 2019
Finance

JPM jump-starts 2019

...Inc. (NASDAQ:CLVS) 31% $24.08 Novocure Ltd. (NASDAQ:NVCR) 29% $43.25 Sosei Group Corp. (Tokyo:4565) 28% ¥1,110 NanoString Technologies Inc....
BioCentury | Jul 20, 2018
Financial News

NanoString prices follow-on, reports preliminary earnings

...Molecular diagnostic company NanoString Technologies Inc. (NASDAQ:NSTG) raised $50 million on July 17 through the sale of 4...
...NanoString's close of $15.10 on July 16 when it proposed the offering after market hours. NanoString...
...Gene Signature Assay (pam50-based gene expression test for breast cancer, NanoString Breast Cancer Intrinsic Subtyping Assay) NanoString Technologies Inc....
BioCentury | Jul 17, 2018
Financial News

NanoString prices follow-on, reports preliminary earnings

...Molecular diagnostic company NanoString Technologies Inc. (NASDAQ:NSTG) raised $50 million through the sale of 4 million shares at...
...by J.P. Morgan, UBS Investment Bank and Baird. The price is a 17% discount to NanoString's...
...Gene Signature Assay (pam50-based gene expression test for breast cancer, NanoString Breast Cancer Intrinsic Subtyping Assay) NanoString Technologies Inc....
BioCentury | Jun 9, 2018
Finance

ASCO ascent

...$31.33 13% Sierra Oncology Inc. (NASDAQ:SRRA) $3.16 12% Oncolytics Biotech Inc. (NASDAQ:ONCY; TSX:ONC) $6.97 11% NanoString Technologies Inc....
BioCentury | Jan 19, 2018
Clinical News

OncoSec reports preliminary Phase I data for ImmunoPulse IL-12 in TNBC

...The open-label, U.S. trial is evaluating changes in the proportion of intratumoral lymphocyte subsets and NanoString-based...
...metastatic triple-negative breast cancer (TNBC) Endpoint: Changes in the proportion of intratumoral lymphocyte subsets and NanoString-based...
BioCentury | Jan 17, 2018
Company News

Management tracks: NanoString, Orchard

...Molecular diagnostics company NanoString Technologies Inc. (NASDAQ:NSTG) hired Thomas Bailey as CFO. He was CFO of AgaMatrix Holdings...
Items per page:
1 - 10 of 103